IC
DGX icon

IKOS CIF’s Quest Diagnostics DGX Stock Holding History

IKOS CIF’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-400
Closed -$27K – 200
2015
Q3 		$27K Buy
400
+279
+231% +$19.5K 0.08% 169
2015
Q2 		$9K Buy
+121
New +$8.93K 0.03% 214
2014
Q3 		– Sell
-3,706
Closed -$222K – 260
2014
Q2 		$222K Buy
+3,706
New +$217K 0.71% 49
2014
Q1 		– Sell
-3,404
Closed -$184K – 241
2013
Q4 		$184K Buy
+3,404
New +$202K 0.47% 81
2013
Q3 		– Sell
-3,065
Closed -$185K – 216
2013
Q2 		$185K Buy
+3,065
New +$183K 0.34% 100

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IKOS CIF's DGX Position: Q4 2015 in Review

IKOS CIF sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 400 shares — an estimated $27K sold.

IKOS CIF first reported a position in DGX in Q2 2013 and held it in 5 quarters. The position peaked at $222K in Q2 2014. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

  • IKOS CIF reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
  • IKOS CIF sold 400 Quest Diagnostics shares in Q4 2015, an estimated $27K.
  • IKOS CIF first reported a position in Quest Diagnostics in Q2 2013 and held it in 5 quarters.
  • IKOS CIF's Quest Diagnostics position peaked at $222K in Q2 2014.
  • 535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on IKOS CIF's 13F filing for Q4 2015, filed 12 Feb 2016.